Avai Bio AVAI
OTC AVAI
$0.11 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Avai Bio (AVAI) FCF Margin (2019 - 2020)

Avai Bio's (AVAI) quarterly FCF Margin came in at 118.1% in Q4 2020, down 375.7% quarter-over-quarter from 42.84% in Q3 2020.

Analysis

Avai Bio (AVAI) FCF Margin (2019 - 2020) Analysis & Trends

Avai Bio has disclosed FCF Margin across 2 years of filings, most recently posting 118.1% for Q4 2020.

  • In Q4 2020, FCF Margin changed N/A year-over-year to 118.1%; the TTM figure through Dec 2020 stood at 2.88% (down 194067.0% YoY), while the FY2023 annual figure was 19.71%, changed N/A from the prior year.
  • FCF Margin came in at 118.1% for Q4 2020 at Avai Bio, down from 42.84% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 42.84% in Q3 2020 to a low of 118.1% in Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Baidu 4.12 Bn -18.28 Bn 1.76 Mn 47.16%
2 Life360 3.37 Bn 3.10 Bn 126.90 Mn 14.38%
3 Soundhound Ai 2.70 Bn 2.50 Bn 27.93 Mn -93.09%
4 C3.ai 1.47 Bn 895.72 Mn 11.32 Mn -106.13%
5 Spectral Capital 455.65 Mn 450.34 Mn 3.28 Mn -0.37%
6 Spire Global 431.21 Mn 339.54 Mn 6.16 Mn -
7 Global AI 147.15 Mn 147.11 Mn 82,446.00 -110.41%
8 Veritone 83.10 Mn 70.68 Mn 15.46 Mn -
9 Agassi Sports Entertainment 81.18 Mn 81.11 Mn - -
10 Avai Bio 15.58 Mn 15.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -118.10%
Sep 30, 2020 42.84%
Jun 30, 2020 -7.95%
Mar 31, 2020 1.53%
Jun 30, 2019 -98.05%